Details of the SBP

General Information of Synthetic Binding Protein (SBP) (ID: SBP001186)
SBP Name
Monobody anti-Abl-SH2 GG10
Synonyms
Monobody GG10
Molecular Weight 10.0 kDa
Design Method Traditional methods (Site-directed mutagenesis and/or Directed evolution)
Expression System Escherichia coli BL21 (DE3)
Selection Method Phage display
Highest Status Research
Sequence Length 95
SBP Sequence
>Monobody anti-Abl-SH2 GG10
VSSVPTKLEVVAATPTSLLISWDAPAVTVDLYVITYGETGGNSPVQEFTVPGSKSTATIS
GLSPGVDYTITVYAGWGNWELGYSWSSPISINYRT
3D Structure
Computationally Modelled Structure
Click to Save PDB File
Template Name Fibronectin type III domain (FN3)
Template Sequence Description X denotes a mixture of 30% Tyr, 15% Ser, 10% Gly, 5% Phe, 5% Trp, and 2.5% each of all the other amino acids except for Cys; O denotes a mixture of Asn, Asp, His, Ile, Leu, Phe, Tyr, and Val; U denotes a mixture of His, Leu, Phe, and Tyr; Z denotes a mixture of Ala, Glu, Lys, and Thr.
Protein Scaffold Information of This SBP
Scaffold ID PS047
Scaffold Info
[1]
Scaffold Name Monobody
Scaffold Class Non-Antibody
Fold Type Beta-Sheets + Loops
Binding Target(s) of This SBP (BTS)
BTS Name Details Mechanism Application Affinity Research Organization Ref
Tyrosine-protein kinase ABL1
BTS Info
Inhibitor Chronic myeloid leukaemia [ICD-11: 2B33.2] Kd: 900 nM University of Chicago [1]
References
1 Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface. J Biol Chem. 2016 Apr 15;291(16):8836-47.